| Literature DB >> 32780485 |
Laura Sinatra1, Jan J Bandolik2, Martin Roatsch1,3, Melf Sönnichsen4, Clara T Schoeder5, Alexandra Hamacher2, Andrea Schöler1, Arndt Borkhardt4, Jens Meiler1,5, Sanil Bhatia4, Matthias U Kassack2, Finn K Hansen1,6.
Abstract
Inhibition of more than one cancer-related pathway by multi-target agents is an emerging approach in modern anticancer drug discovery. Here, based on the well-established synergy between histone deacetylase inhibitors (HDACi) and alkylating agents, we present the discovery of a series of alkylating HDACi using a pharmacophore-linking strategy. For the parallel synthesis of the target compounds, we developed an efficient solid-phase-supported protocol using hydroxamic acids immobilized on resins (HAIRs) as stable and versatile building blocks for the preparation of functionalized HDACi. The most promising compound, 3 n, was significantly more active in apoptosis induction, activation of caspase 3/7, and formation of DNA damage (γ-H2AX) than the sum of the activities of either active principle alone. Furthermore, to demonstrate the utility of our preloaded resins, the HAIR approach was successfully extended to the synthesis of a proof-of-concept proteolysis-targeting chimera (PROTAC), which efficiently degrades histone deacetylases.Entities:
Keywords: DNA damage; PROTAC; histone deacetylase; multi-target drugs; solid-phase synthesis
Year: 2020 PMID: 32780485 PMCID: PMC7756583 DOI: 10.1002/anie.202006725
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336